A diverse scientific program, punctuated by distinguished plenary speakers, draws attendees year after year to AAIC: the largest and most influential international forum to advance dementia science.

Explore the full AAIC 2022 conference program. Registered attendees, plan your schedule.

Please refer to the daily addenda for program changes. The ALZ Meetings on-site attendee mobile app and the AAIC virtual platform will have the most up-to-date program information.

All events will take place at the San Diego Convention Center unless otherwise noted. Times are listed in Pacific Time (North America).

On This Page:

• > Basic Science and Pathogenesis
• > Biomarkers
• > Clinical Manifestations
• > Dementia Care and Psychosocial Factors and Public Health
• > Drug Development

Basic Science and Pathogenesis

• Plenary session: Astrocytes in Neurodegenerative Disorders
  Presented by Carole Escartin, Université Paris-Saclay/CNRS, France
• Plenary session: Inge Grundke-Iqbal Award for Alzheimer’s Research: Tau Oligomer Induced HMGB1 Release Contributes to Cellular Senescence and Neuropathology Linked to Alzheimer’s Disease and Frontotemporal Dementia
  Presented by Rakez Kayed, University of Texas Medical Branch, Galveston, United States
• Mechanisms Underlying Lifestyle Interventions in AD
• Traumatic Brain Injury and Dementia

Biomarkers

• Plenary session: The Role of Biomarkers in Preventative Clinical Trials in Alzheimer's Disease: Perspectives from a South American Country
  Presented by Francisco Lopera, Neurosciences Group of Antioquia, University of Antioquia, Colombia
• Plenary session: Neuropathology in the Era of In-Vivo Biomarkers
  Presented by Thomas Beach, Banner Sun Health Research Institute, United States
• The Road to Clinical Implementation of Plasma Biomarkers
• Biomarker Discovery in Global and Diverse Landscapes

Clinical Manifestations

• Plenary session: Apathy in Neurodegenerative Diseases
  Presented by Krista Lanctôt, Sunnybrook Health Sciences Centre, Canada
• Remote Assessment of Preclinical Cognitive Change

Dementia Care and Psychosocial Factors and Public Health

• Plenary session: Aging In Homeless Populations
  Presented by Margot Kushel, University of California, San Francisco, United States
• Plenary session: Non-Pharmacological Care, Behavior Change, MCI
  Presented by Linda Lam, Chinese University of Hong Kong, Hong Kong
• Plenary session: The Interface of Delirium and Dementia
  Presented by Sharon K. Inouye, Harvard Medical School, United States
• Innovative Methods in ADRD Epidemiology Research

Drug Development

• Plenary session: Next-Generation Alzheimer’s Therapeutics: Leveraging Deep Biology
  Presented by Frank M. Longo, Stanford University, United States
• Drug Repositioning and Alzheimer’s Clinical Trials
• Immune Metabolism and Gut Microbiome in Alzheimer’s Disease